• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Carboplatin and epirubicin combination therapy for advanced malignant epithelial skin tumors: Retrospective study of six patients.

作者信息

Nakamura Yoshio, Tanese Keiji, Hirai Ikuko, Kawakami Yutaka, Funakoshi Takeru

机构信息

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.

Division of Cellular Signaling for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.

出版信息

J Dermatol. 2018 Jul;45(7):874-875. doi: 10.1111/1346-8138.14328.

DOI:10.1111/1346-8138.14328
PMID:29971836
Abstract
摘要

相似文献

1
Carboplatin and epirubicin combination therapy for advanced malignant epithelial skin tumors: Retrospective study of six patients.卡铂和表柔比星联合治疗晚期恶性上皮性皮肤肿瘤：6例患者的回顾性研究。
J Dermatol. 2018 Jul;45(7):874-875. doi: 10.1111/1346-8138.14328.
2
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial.与表柔比星加紫杉醇相比，卡铂加紫杉醇作为局部晚期三阴性乳腺癌新辅助化疗的病理完全缓解和无复发生存情况更佳：一项随机2期试验。
Oncotarget. 2016 Sep 13;7(37):60647-60656. doi: 10.18632/oncotarget.10607.
3
[Clinical experience in the treatment of ovarian carcinoma and the role of the nurse during the hemotherapy].
Akush Ginekol (Sofiia). 2009;48 Suppl 2:33-6.
4
Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicin.三例晚期皮肤鳞状细胞癌采用卡铂和表柔比星联合治疗。
Eur J Hosp Pharm. 2020 Mar;27(2):128. doi: 10.1136/ejhpharm-2019-002123. Epub 2019 Nov 11.
5
Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.卡铂和表柔比星联合化疗治疗晚期子宫内膜癌。
Anticancer Res. 2014 Jul;34(7):3793-8.
6
A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.一项改良剂量密度紫杉醇和每 4 周卡铂治疗晚期原发性上皮性卵巢、输卵管或腹膜癌的 II 期研究。
Cancer Chemother Pharmacol. 2013 Jul;72(1):101-7. doi: 10.1007/s00280-013-2173-2. Epub 2013 May 10.
7
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.紫杉醇、表柔比星和顺铂用于晚期或复发性子宫内膜癌：一项希腊合作肿瘤学组（HeCOG）的研究。
Gynecol Oncol. 2008 Jul;110(1):87-92. doi: 10.1016/j.ygyno.2008.03.004. Epub 2008 May 2.
8
Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy.
J Dermatol. 2015 Sep;42(9):928-30. doi: 10.1111/1346-8138.12977. Epub 2015 Jun 13.
9
Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.卡铂、异环磷酰胺和美司钠治疗子宫癌肉瘤的化疗
Anticancer Res. 2015 Sep;35(9):4841-7.
10
[Evaluation of second-line chemotherapies most often used in recurrent epithelial ovarian cancer].[复发性上皮性卵巢癌最常用的二线化疗评估]
Orv Hetil. 2007 Dec 9;148(49):2337-42. doi: 10.1556/OH.2007.28132.

引用本文的文献

1
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.具有大汗腺和小汗腺分化的皮肤附件肿瘤的当前诊断和治疗选择。
Int J Mol Sci. 2021 May 11;22(10):5077. doi: 10.3390/ijms22105077.
2
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).抗程序性死亡蛋白 1（PD-1）抗体治疗上皮性皮肤恶性肿瘤：一项研究者发起的、开放标签、单臂、多中心 II 期临床试验（非黑素瘤皮肤癌 - PD1 研究）
Medicine (Baltimore). 2020 Oct 30;99(44):e22913. doi: 10.1097/MD.0000000000022913.
3
Three cases of advanced cutaneous squamous cell carcinoma treated with a combination of carboplatin and epirubicin.
三例晚期皮肤鳞状细胞癌采用卡铂和表柔比星联合治疗。
Eur J Hosp Pharm. 2020 Mar;27(2):128. doi: 10.1136/ejhpharm-2019-002123. Epub 2019 Nov 11.
4
Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of Immunotherapies.表皮生长因子受体在皮肤鳞状细胞癌中的作用及其在免疫治疗时代作为治疗靶点的作用。
Curr Treat Options Oncol. 2020 Feb 3;21(1):9. doi: 10.1007/s11864-019-0697-3.
5
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer.晚期非黑素瘤皮肤癌全身治疗的进展
Front Med (Lausanne). 2019 Jul 10;6:160. doi: 10.3389/fmed.2019.00160. eCollection 2019.